Shopping Cart
- Remove All
- Your shopping cart is currently empty
EMT Inhibitor-2, targeting both CYP3A4 testosteron and CYP2C9, exhibits inhibitory effects with IC50 values of 49.72 and 5.54 μM, respectively. Furthermore, it effectively impedes the epithelial-mesenchymal transition (EMT) process, induced by immunocyte-released agents like IL-1β and TGF-β.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,400 | 8-10 weeks | |
50 mg | $1,820 | 8-10 weeks | |
100 mg | $2,820 | 8-10 weeks |
Description | EMT Inhibitor-2, targeting both CYP3A4 testosteron and CYP2C9, exhibits inhibitory effects with IC50 values of 49.72 and 5.54 μM, respectively. Furthermore, it effectively impedes the epithelial-mesenchymal transition (EMT) process, induced by immunocyte-released agents like IL-1β and TGF-β. |
Molecular Weight | 470.47 |
Formula | C24H26N2O8 |
Cas No. | 2232228-60-1 |
Relative Density. | 1.320 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.